Newsfeeds - Spark Newswire

1 minute read

Deciphera Pharmaceuticals Q2 EPS $(1.21) Misses $(1.15) Estimate, Sales $23.57M Beat $22.00M Estimate

Today, 3:31 AM

Deciphera Pharmaceuticals (NASDAQ:DCPH) reported quarterly losses of $(1.21) per share which missed the analyst consensus estimate of $(1.15) by 5.22 percent. This is a 0.83 percent decrease over losses of $(1.20) per

DCPH

21 minute read

Earnings Scheduled For August 3, 2021

By Benzinga Insights

Today, 3:31 AM

Companies Reporting Before The Bell • Myriad Genetics (NASDAQ:MYGN) is likely to report earnings for its fourth quarter. • Stellantis (NYSE:STLA) is expected to report earnings for its second quarter.

AAIC

1 minute read

Events
News

Deciphera Pharmaceuticals Presents Data from QINLOCK® and Rebastinib Programs at the 2021 American Society of Clinical Oncology Annual Meeting

By Benzinga Newsdesk

Today, 3:31 AM

– Exploratory Analysis of the INVICTUS Phase 3 Study Showed QINLOCK Dose Escalation After Disease Progression Provided Substantial Clinical Benefit in Advanced GIST – – Rebastinib in Combination with

DCPH

7 minute read

The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes

By Shanthi Rexaline

Today, 3:31 AM

After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-specific news flow dictated stock moves during the week.

ADAP

5 minute read

Uncategorized

The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts

By Shanthi Rexaline

Today, 3:31 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13)

ACHL

7 minute read

Uncategorized

The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron

By Shanthi Rexaline

Today, 3:31 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11)

ABIO

6 minute read

Uncategorized

The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings

By Shanthi Rexaline

Today, 3:31 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10)

ABBV

5 minute read

Uncategorized

70 Biggest Movers From Yesterday

By Lisa Levin

Today, 3:31 AM

Gainers Nemaura Medical Inc. (NASDAQ: NMRD) shares surged 135.3% to close at $11.06 on Wednesday after the company receipt of a purchase order for 5,000 sugarBEAT transmitters and 200,000 sugarBEAT sensors from its U.K. licensee, DB Ethitronix Ltd.

ADMP

20 minute read

Uncategorized

Earnings Scheduled For May 4, 2021

By Benzinga Insights

Today, 3:31 AM

Companies Reporting Before The Bell • Lancaster Colony (NASDAQ:LANC) is likely to report quarterly earnings at $1.24 per share on revenue of $340.02 million.

ACLS